{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:26:44Z","timestamp":1790490404470,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","award":["HFNZ1417"],"award-info":[{"award-number":["HFNZ1417"]}],"id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008354","name":"Callaghan Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0894-1","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:24:30Z","timestamp":1534321470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes"],"prefix":"10.1186","volume":"18","author":[{"given":"Edward C. A.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Pilbrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim G.","family":"Yandle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice C.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Pattinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Gieseg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-5033","authenticated-orcid":false,"given":"Barry R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"issue":"6","key":"894_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376.","journal-title":"Nat Med"},{"issue":"7","key":"894_CR2","doi-asserted-by":"publisher","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2012;2(7):a006502.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6535","key":"894_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/376066a0","volume":"376","author":"GH Fong","year":"1995","unstructured":"Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376(6535):66\u201370.","journal-title":"Nature"},{"issue":"8","key":"894_CR4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cvr\/28.8.1176","volume":"28","author":"S Banai","year":"1994","unstructured":"Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 1994;28(8):1176\u20139.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"894_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ki.1997.60","volume":"51","author":"P Sandner","year":"1997","unstructured":"Sandner P, Wolf K, Bergmaier U, Gess B, Kurtz A. Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int. 1997;51(2):448\u201353.","journal-title":"Kidney Int"},{"issue":"3","key":"894_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood.V97.3.785","volume":"97","author":"A Sawano","year":"2001","unstructured":"Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T, et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 2001;97(3):785\u201391.","journal-title":"Blood"},{"issue":"2","key":"894_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ceb.2012.02.002","volume":"24","author":"A Eichmann","year":"2012","unstructured":"Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol. 2012;24(2):188\u201393.","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"894_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0968-0004(03)00193-2","volume":"28","author":"MJ Cross","year":"2003","unstructured":"Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci. 2003;28(9):488\u201394.","journal-title":"Trends Biochem Sci"},{"issue":"2 Pt 2","key":"894_CR9","first-page":"H586","volume":"265","author":"DD Ku","year":"1993","unstructured":"Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265(2 Pt 2):H586\u201392.","journal-title":"Am J Physiol"},{"issue":"6","key":"894_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0958-1669(99)00032-4","volume":"10","author":"W Schaper","year":"1999","unstructured":"Schaper W, Buschmann I. VEGF and therapeutic opportunities in cardiovascular diseases. Curr Opin Biotech. 1999;10(6):541\u20133.","journal-title":"Curr Opin Biotech"},{"issue":"Pt 17","key":"894_CR11","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1242\/jcs.00673","volume":"116","author":"A Orecchia","year":"2003","unstructured":"Orecchia A, Lacal PM, Schietroma C, Morea V, Zambruno G, Failla CM. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J Cell Sci. 2003;116(Pt 17):3479\u201389.","journal-title":"J Cell Sci"},{"issue":"5","key":"894_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/cs1000567","volume":"100","author":"FM Belgore","year":"2001","unstructured":"Belgore FM, Blann AD, Lip GY. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays. Clin Sci (Lond). 2001;100(5):567\u201375.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"894_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/eurheartj\/ehq429","volume":"32","author":"W Hochholzer","year":"2011","unstructured":"Hochholzer W, Reichlin T, Stelzig C, Hochholzer K, Meissner J, Breidthardt T, et al. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur Heart J. 2011;32(3):326\u201335.","journal-title":"Eur Heart J"},{"issue":"9","key":"894_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.107.703959","volume":"116","author":"P Meier","year":"2007","unstructured":"Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007 Aug 28;116(9):975\u201383.","journal-title":"Circulation"},{"issue":"3","key":"894_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7","volume":"190","author":"I Buschmann","year":"2000","unstructured":"Buschmann I, Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol. 2000;190(3):338\u201342.","journal-title":"J Pathol"},{"issue":"2","key":"894_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3(2):175\u201387.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"894_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0218492312458511","volume":"21","author":"P Gurumurthy","year":"2013","unstructured":"Gurumurthy P, Borra SK, Yeruva RK, Babu S, Thomas J, Cherian KM. Estimation of serum neopterin in patients with acute coronary syndrome. Asian Cardiovasc Thorac Ann. 2013;21(4):426\u201331.","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"4","key":"894_CR18","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.4238\/2013.October.7.8","volume":"12","author":"ZY Liu","year":"2013","unstructured":"Liu ZY, Li YD. Relationship between serum neopterin levels and coronary heart disease. Genet Mol Res. 2013;12(4):4222\u20139.","journal-title":"Genet Mol Res"},{"issue":"3","key":"894_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/pterid-2015-0004","volume":"26","author":"T Janmale","year":"2015","unstructured":"Janmale T, Genet R, Crone E, Flavall E, Firth C, Pirker J, et al. Neopterin and 7,8-dihydroneopterin are generated within atherosclerotic plaques. Pteridines. 2015;26(3):93\u2013103.","journal-title":"Pteridines"},{"issue":"5","key":"894_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.amjcard.2003.11.035","volume":"93","author":"P Avanzas","year":"2004","unstructured":"Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC. Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol. 2004;93(5):627\u20139.","journal-title":"Am J Cardiol"},{"issue":"4","key":"894_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ahj.2008.06.013","volume":"156","author":"BR Palmer","year":"2008","unstructured":"Palmer BR, Jarvis MD, Pilbrow AP, Ellis KL, Frampton CM, Skelton L, et al. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J. 2008;156(4):752\u20138.","journal-title":"Am Heart J"},{"issue":"3","key":"894_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1540-8167.2011.02192.x","volume":"23","author":"BR Palmer","year":"2012","unstructured":"Palmer BR, Frampton CM, Skelton L, Yandle TG, Doughty RN, Whalley GA, et al. KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients. J Cardiovasc Electrophysiol. 2012;23(3):319\u201324.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"894_CR23","doi-asserted-by":"publisher","first-page":"e89029","DOI":"10.1371\/journal.pone.0089029","volume":"9","author":"BR Palmer","year":"2014","unstructured":"Palmer BR, Slow S, Ellis KL, Pilbrow AP, Skelton L, Frampton CM, et al. Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients. PloS one. 2014;9(3):e89029.","journal-title":"PloS one"},{"issue":"3","key":"894_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCGENETICS.109.917443","volume":"3","author":"KL Ellis","year":"2010","unstructured":"Ellis KL, Pilbrow AP, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, et al. A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. Circ Cardiovasc Genet. 2010;3(3):286\u201393.","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"894_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/jhh.2012.24","volume":"27","author":"KL Ellis","year":"2013","unstructured":"Ellis KL, Palmer BR, Frampton CM, Troughton RW, Doughty RN, Whalley GA, et al. Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease. J Hum Hypertens. 2013;27(4):237\u201344.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"894_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1440-1681.2009.05261.x","volume":"37","author":"MD Jarvis","year":"2010","unstructured":"Jarvis MD, Palmer BR, Pilbrow AP, Ellis KL, Frampton CM, Skelton L, et al. CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndromes patients. Clin Exp Pharmacol Physiol. 2010;37(2):193\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"894_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/pme.12.10","volume":"9","author":"KL Ellis","year":"2012","unstructured":"Ellis KL, Pilbrow AP, Potter HC, Frampton CM, Doughty RN, Whalley GA, et al. Association between endothelin type A receptor haplotypes and mortality in coronary heart disease. Pers Med. 2012;9(3):341\u20139.","journal-title":"Pers Med"},{"issue":"8","key":"894_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jacc.2007.04.074","volume":"50","author":"Y Wang","year":"2007","unstructured":"Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, et al. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol. 2007;50(8):760\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"894_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0735-1097(85)80380-6","volume":"5","author":"KP Rentrop","year":"1985","unstructured":"Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5(3):587\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"894_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0009-9260(77)80140-2","volume":"28","author":"PWT Brandt","year":"1977","unstructured":"Brandt PWT, Partridge JB, Wattie WJ. Coronary arteriography - method of presentation of arteriogram report and a scoring system. Clin Radiol. 1977;28(4):361\u20135.","journal-title":"Clin Radiol"},{"issue":"22","key":"894_CR31","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1161\/01.CIR.0000070953.76250.B9","volume":"107","author":"AM Richards","year":"2003","unstructured":"Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 2003;107(22):2786\u201392.","journal-title":"Circulation"},{"issue":"9","key":"894_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/02640414.2014.971047","volume":"33","author":"A Lindsay","year":"2015","unstructured":"Lindsay A, Lewis J, Scarrott C, Draper N, Gieseg SP. Changes in acute biochemical markers of inflammatory and structural stress in rugby union. J Sports Sci. 2015;33(9):882\u201391.","journal-title":"J Sports Sci"},{"issue":"10","key":"894_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2169\/internalmedicine.52.9073","volume":"52","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, Uemura S, Takeda Y, Matsui M, Okada S, Nishida T, et al. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease. Intern Med. 2013;52(10):1019\u201327.","journal-title":"Intern Med"},{"issue":"4","key":"894_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000367807","volume":"51","author":"D Morrow","year":"2014","unstructured":"Morrow D, Hatch E, Hamm K, Cahill PA, Redmond EM. Flk-1\/KDR mediates ethanol-stimulated endothelial cell Notch signaling and angiogenic activity. J Vasc Res. 2014;51(4):315\u201324.","journal-title":"J Vasc Res"},{"issue":"5","key":"894_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1360-0443.2010.02899.x","volume":"105","author":"J Rehm","year":"2010","unstructured":"Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817\u201343.","journal-title":"Addiction"},{"issue":"1","key":"894_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","volume":"134","author":"J Andersson","year":"2010","unstructured":"Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol. 2010;134(1):33\u201346.","journal-title":"Clin Immunol"},{"issue":"24","key":"894_CR37","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1161\/CIRCULATIONAHA.106.666511","volume":"115","author":"KK Ray","year":"2007","unstructured":"Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, et al. Long-term prognostic value of neopterin a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation. 2007;115(24):3071\u20138.","journal-title":"Circulation"},{"issue":"25","key":"894_CR38","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","volume":"101","author":"G Liuzzo","year":"2000","unstructured":"Liuzzo G, Goronzy JJ, Yang HY, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101(25):2883\u20138.","journal-title":"Circulation"},{"issue":"3","key":"894_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/heart.83.3.346","volume":"83","author":"X Garcia-Moll","year":"2000","unstructured":"Garcia-Moll X, Cole D, Zouridakis E, Kaski JC. Increased serum neopterin: a marker of coronary artery disease activity in women. Heart. 2000;83(3):346\u201350.","journal-title":"Heart"},{"issue":"5","key":"894_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1365-2710.2001.00358.x","volume":"26","author":"A Berdowska","year":"2001","unstructured":"Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther. 2001;26(5):319\u201329.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"894_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1203\/01.PDR.0000145280.26284.B9","volume":"56","author":"H Kariyazono","year":"2004","unstructured":"Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res. 2004;56(6):953\u20139.","journal-title":"Pediatr Res"},{"issue":"6535","key":"894_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376(6535):62\u20136.","journal-title":"Nature"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0894-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T15:44:07Z","timestamp":1568907847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0894-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0894-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the New Zealand (NZ) Multi-Region Ethics Committee and all participating patients provided written, informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable \u2013 this article does not report an individual participant\u2019s data in any form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BRP is a member of the Editorial Board of BMC Cardiovascular Disorders. The other authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"169"}}